India's Orchid Pharma slides on quarterly profit fall
** Shares of India's Orchid Pharma ORCD.NS drop nearly 5% to 705 rupees ** Drugmaker's Q4 profit after tax fell 15% y/y, as higher expenses overshadowed a 9% sales rise ** Trading vols at 183k shares, more than twice the 30-day avg ** YTD stock has shed 61% (Reporting by Hritam Mukherjee in Bengaluru) ((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices